Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes

被引：0
|
作者：
Zirui Hao
Yue Sun
Guiping Li
Yuli Shen
Yingzhen Wen
Yan Liu
机构：
[1] the Third People’s Hospital of Huizhou,Department of Endocrinology
[2] Affiliated Huizhou Hospital of Guangzhou Medical University,Department of Cardiology
[3] The First People’s Hospital of Huizhou,undefined
来源：
BMC Endocrine Disorders | / 22卷
关键词：
Diabetes mellitus; Insulin resistance; Visceral adipose tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Food addiction behavior in patients with newly-diagnosed type 2 diabetes
    Lavielle, Pilar
    Gomez-Diaz, Rita A.
    Valdez, Leticia
    Wacher, Niels H.
    GACETA MEDICA DE MEXICO, 2023, 159 (05): : 426 - 433
  • [22] THE EFFECTS OF VOGLIBOSE AND GLIMEPIRIDE ON ADIPOSE TISSUE AND METABOLIC PARAMETERS IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Nam, J. S.
    Kim, M. K.
    Baek, H.
    Lee, M. Y.
    Ahn, C. W.
    Cha, B. S.
    Kim, K. R.
    Lee, H. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S143 - S143
  • [23] Effects of voglibose and glimepiride on adipose tissue and metabolic abnormalities in patients with newly diagnosed obese type 2 diabetes
    Kim, C. S.
    Park, J. S.
    Nam, J. Y.
    Park, J.
    Kim, H. J.
    Noh, T. W.
    Nam, J. S.
    Kang, E. S.
    Ahn, C. W.
    Cha, B. S.
    Lim, S. K.
    Kim, K. R.
    Lee, H. C.
    DIABETES, 2006, 55 : A482 - A482
  • [24] Predictors of Metformin Side Effects in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Alibrahim, Nassar Taha Yaseen
    Chasib, Mohammed Ghazi
    Hamadi, Saad Shaheen
    Mansour, Abbas Ali
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2023, 15 (02): : 67 - 73
  • [25] Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes
    Hong-wei GAO Chao XIE Hai-ning WANG Yu-jing LIN Tian-pei HONG Department of Endocrinology
    ActaPharmacologicaSinica, 2007, (04) : 534 - 539
  • [26] Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes
    Gao, Hong-Wei
    Xie, Chao
    Wang, Hai-Ning
    Lin, Yu-Jing
    Hong, Tian-Pei
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (04) : 534 - 539
  • [27] Relationship of chronic vascular complications with beta cell dysfunction and insulin resistance in newly-diagnosed type 2 diabetes. The VNDS Study
    Dauriz, M.
    Trombetta, M.
    Santi, L.
    Boselli, M.
    Brangani, C.
    Pichiri, I.
    Travia, D.
    Cacciatori, V.
    Negri, C.
    Stoico, V.
    Bonadonna, R. C.
    Bonora, E.
    DIABETOLOGIA, 2017, 60 : S502 - S502
  • [28] The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes
    Antonio-Villa, N. E.
    Bello-Chavolla, O. Y.
    Vargas-Vazquez, A.
    Mehta, R.
    Aguilar-Salinas, C. A.
    DIABETIC MEDICINE, 2020, 37 (07) : 1192 - 1201
  • [29] Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes
    Hong-wei Gao
    Chao Xie
    Hai-ning Wang
    Yu-jing Lin
    Tian-pei Hong
    Acta Pharmacologica Sinica, 2007, 28 : 534 - 539
  • [30] Progression from High Insulin Resistance to Type 2 Diabetes Does Not Entail Additional Visceral Adipose Tissue Inflammation
    Barbarroja, Nuria
    Lopez-Pedrera, Chary
    Garrido-Sanchez, Lourdes
    Dolores Mayas, Maria
    Oliva-Olivera, Wilfredo
    Rosa Bernal-Lopez, Maria
    El Bekay, Rajaa
    Jose Tinahones, Francisco
    PLOS ONE, 2012, 7 (10):
12345